Jun 10, 2026 08:02AM
Jun 10, 2026 08:00AM
May 7, 2026 07:00AM
May 4, 2026 08:04AM
May 4, 2026 08:00AM
Apr 14, 2026 10:59AM
Apr 13, 2026 08:03AM Akebia begins dosing patients in Phase 1 trial of AKB-9090
Apr 13, 2026 08:00AM
Apr 1, 2026 04:05PM
Apr 1, 2026 04:05PM
Mar 19, 2026 04:05PM
Feb 26, 2026 07:00AM
Jan 12, 2026 08:02AM
Jan 12, 2026 08:00AM Akebia Therapeutics Announces Corporate Updates and 2026 Pipeline Outlook
Jan 6, 2026 08:01AM
Jan 6, 2026 08:00AM
Dec 1, 2025 07:00AM
Nov 10, 2025 07:00AM
Nov 6, 2025 06:30PM
Oct 28, 2025 04:30PM
Oct 28, 2025 04:30PM Akebia Therapeutics Provides Update on Vafseo for Non-Dialysis Patients
Oct 20, 2025 08:08AM
Aug 21, 2025 08:01AM
Aug 21, 2025 08:00AM
Aug 7, 2025 07:00AM
Aug 4, 2025 08:00AM
Jun 4, 2025 08:01AM
Jun 4, 2025 08:00AM Vadadustat U.S. Patient Data from Global Phase 3 Clinical Program Published in Journal of the American Society of Nephrology
May 8, 2025 07:00AM
Apr 3, 2025 08:01AM
Apr 3, 2025 08:00AM
Mar 13, 2025 07:00AM
Jan 13, 2025 08:06AM
Jan 13, 2025 08:00AM
Dec 3, 2024 07:00AM U.S. Renal Care Enrolled First Patients in the VOICE Collaborative Clinical Trial of Vafseo® (vadadustat) for CKD Patients on Dialysis
Nov 14, 2024 08:00AM
Nov 7, 2024 07:00AM
Oct 22, 2024 08:03AM
Oct 22, 2024 08:00AM
Oct 15, 2024 08:00AM
Oct 11, 2024 06:37AM
Oct 10, 2024 08:02AM Akebia Therapeutics (AKBA) Reports CMS Grants TDAPA Reimbursement for Vafseo beginning January 1, 2025
Oct 10, 2024 08:00AM
Oct 8, 2024 06:49AM
Oct 7, 2024 08:05AM
Oct 7, 2024 08:00AM
Sep 5, 2024 08:05AM
Sep 5, 2024 08:00AM
Aug 8, 2024 07:00AM Akebia Therapeutics Reports Second Quarter 2024 Financial Results and Recent Business Highlights
Jul 11, 2024 06:01AM

323,573 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All